Navigation Links
Author Royalties From Autism Book Donated to Autism Research
Date:11/3/2008

PHILADELPHIA, Nov. 3 /PRNewswire-USNewswire/ -- Paul Offit, MD, announced today that all author royalties earned from the sale of his new book, "Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure," will be donated to the Center for Autism Research at Children's Hospital of Philadelphia.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081103/DC43575)

"We are very pleased to partner with Dr. Offit, and to accept the royalties of his book for the work done here at the Center for Autism Research (CAR) at Children's Hospital of Philadelphia," said Dr. Bob Schultz, director of the Center for Autism Research at Children's Hospital. "CAR is dedicated to helping children with an autism spectrum disorder (ASD) and their families. CAR's mission is to identify the causes of ASD, and from that knowledge devise effective treatments. By donating profits from his book, Dr. Offit is helping to push science forward for the good of all."

Dr. Offit, who is chief of Infectious Disease and director of the Vaccine Education Center at Children's Hospital, recounts the history of autism research and argues that antivaccination forces have misled the public by claiming a false link between vaccines and autism, a challenging neurological condition whose true cause remains unknown.

Dr. Offit's book underscores the importance of dedicating scarce social resources toward supporting legitimate scientific research into autism, rather than being needlessly diverted into implausible and scientifically unsupported treatments.

Paul A. Offit, M.D. is the chief of Infectious Diseases and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and professor of pediatrics at the University of Pennsylvania School of Medicine. He has received numerous awards, including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland School of Medicine, the Young Investigator Award in Vaccine Development from the Infectious Diseases Society of America, and a Research Career Development Award from the National Institutes of Health. An international expert on rotavirus-specific immune responses, Dr. Offit is the co-inventor of the rotavirus vaccine RotaTeq, for which he received the Jonas Salk Award from the Association for Professionals in Infection Control and Epidemiology, the Gold Medal from the Children's Hospital of Philadelphia, and the Stanley A. Plotkin Award in Vaccinology from the Pediatric Infectious Diseases Society.

Media Contact:

Rachel Salis-Silverman

The Children's Hospital of Philadelphia

267-426-6063

Salis@email.chop.edu


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Author royalties from autism book donated to autism research
2. Pennsylvania Patient Safety Authority Hires Director of Educational Programs
3. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
4. CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
5. New Jersey Author Uncovers the Secret to Well-Being Is the Connection Between Health and Emotions
6. Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program
7. New Author Mary Soliel Honored as Two-time National Best Books 2008 Award Finalist
8. Patient Safety Authority Supports International Infection Prevention Week
9. American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008
10. Exercise Can Help You Cope with Financial Stress and Heal Emotional Pain, Says Acclaimed Author and Psychotherapist
11. Mt. Sinai Services Toronto Becomes an Xceed Authorized Gene-Expression Service Provider Using Ziplex(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: